ABT Earnings Abbott Laboratories
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | 0.61 | 2026-04-29 | 10-Q |
| FY 2025 | 2025-12-31 | 3.72 | 2026-02-20 | 10-K |
| Q3 2025 | 2025-09-30 | 2.70 | 2025-10-29 | 10-Q |
| Q2 2025 | 2025-06-30 | 1.77 | 2025-07-30 | 10-Q |
| Q1 2026 | 2025-03-31 | 0.76 | 2026-04-29 | 10-Q |
| FY 2025 | 2024-12-31 | 7.64 | 2026-02-20 | 10-K |
| Q3 2025 | 2024-09-30 | 2.38 | 2025-10-29 | 10-Q |
| Q2 2025 | 2024-06-30 | 1.44 | 2025-07-30 | 10-Q |
| Q1 2025 | 2024-03-31 | 0.70 | 2025-04-30 | 10-Q |
| FY 2025 | 2023-12-31 | 3.26 | 2026-02-20 | 10-K |
| Q3 2024 | 2023-09-30 | 2.35 | 2024-10-31 | 10-Q |
| Q2 2024 | 2023-06-30 | 1.53 | 2024-07-31 | 10-Q |
| Q1 2024 | 2023-03-31 | 0.75 | 2024-05-02 | 10-Q |
| FY 2024 | 2022-12-31 | 3.91 | 2025-02-21 | 10-K |
| Q3 2023 | 2022-09-30 | 3.32 | 2023-11-01 | 10-Q |
| Q2 2023 | 2022-06-30 | 2.51 | 2023-08-03 | 10-Q |
| Q1 2023 | 2022-03-31 | 1.37 | 2023-05-04 | 10-Q |
| FY 2023 | 2021-12-31 | 3.94 | 2024-02-16 | 10-K |
| Q3 2022 | 2021-09-30 | 2.83 | 2022-11-01 | 10-Q |
| Q2 2022 | 2021-06-30 | 1.66 | 2022-08-02 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.